Hodgkin lymphoma (HL), and post-GC tumors such as splenic- and mucosa-associated lymphoid tissue (MALT) types of marginal zone lymphoma (MZL), as well as multiple myeloma (MM), are all consistently negative for TCL1A [12]. This evidence concerns the gene TCL1A and marginal zone lymphoma.